Business Description
Guardant Health Inc
NAICS : 621511
SIC : 8071
ISIN : US40131M1099
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.86 | |||||
Equity-to-Asset | 0.09 | |||||
Debt-to-Equity | 8.53 | |||||
Debt-to-EBITDA | -3.12 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.66 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.6 | |||||
3-Year EBITDA Growth Rate | -18.8 | |||||
3-Year EPS without NRI Growth Rate | -18.1 | |||||
3-Year FCF Growth Rate | -24 | |||||
3-Year Book Growth Rate | -53.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 27.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 24.27 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.26 | |||||
9-Day RSI | 48.33 | |||||
14-Day RSI | 46.62 | |||||
6-1 Month Momentum % | -34.02 | |||||
12-1 Month Momentum % | -28.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.54 | |||||
Quick Ratio | 6.24 | |||||
Cash Ratio | 5.68 | |||||
Days Inventory | 95.68 | |||||
Days Sales Outstanding | 58.06 | |||||
Days Payable | 111.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 0.64 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 59.74 | |||||
Operating Margin % | -100.14 | |||||
Net Margin % | -85.02 | |||||
FCF Margin % | -61.26 | |||||
ROE % | -344.76 | |||||
ROA % | -28.05 | |||||
ROIC % | -105.86 | |||||
ROC (Joel Greenblatt) % | -147.12 | |||||
ROCE % | -31.69 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.59 | |||||
PB Ratio | 13.87 | |||||
Price-to-Tangible-Book | 15.03 | |||||
EV-to-EBIT | -5.02 | |||||
EV-to-Forward-EBIT | -5.31 | |||||
EV-to-EBITDA | -5.51 | |||||
EV-to-Forward-EBITDA | -6.98 | |||||
EV-to-Revenue | 4.23 | |||||
EV-to-Forward-Revenue | 3.6 | |||||
EV-to-FCF | -6.91 | |||||
Earnings Yield (Greenblatt) % | -19.92 | |||||
FCF Yield % | -15.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Guardant Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 523.012 | ||
EPS (TTM) (€) | -3.965 | ||
Beta | 0.83 | ||
Volatility % | 56.69 | ||
14-Day RSI | 46.62 | ||
14-Day ATR (€) | 0.590642 | ||
20-Day SMA (€) | 16.683 | ||
12-1 Month Momentum % | -28.13 | ||
52-Week Range (€) | 15.02 - 36.6 | ||
Shares Outstanding (Mil) | 121.71 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guardant Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guardant Health Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Guardant Health Inc Frequently Asked Questions
What is Guardant Health Inc(FRA:5GH)'s stock price today?
When is next earnings date of Guardant Health Inc(FRA:5GH)?
Does Guardant Health Inc(FRA:5GH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |